Purchase Order 75N91019P00379
Award Date 5/23/19
Potential Completion Date 6/23/19
Potential Value $14K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,478.46 on June 24, 2019, for drugs and biologicals with a completion date of July 31, 2019. Work is performed in Grand Island, New York. This firm fixed-price order procures specialized biomedical research instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio—the vendor operates as a direct supplier of genetic analysis instruments, immunoassay systems, flow...
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,621.46 on November 20, 2019, with an ultimate completion date of December 19, 2019. The order procures drugs and biologicals on a firm fixed-price basis. Place of performance is Grand Island, New York.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,960 on July 19, 2017, for laboratory supplies, with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, manufactures laboratory instrumentation, reagents, and consumables supplied across federal research and diagnostic sectors.</p>
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $14,599.10 on July 18, 2017, for laboratory supplies with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs across the life sciences...
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation on December 7, 2018, for $13,158.00, with ultimate completion on January 16, 2019. No set-aside was used. Performance takes place in Grand Island, New York. The order is for firm fixed-price supply of specialized biomedical research instruments, reagents, or consumables typical of Life Technologies' federal portfolio in genetic analysis, immunoassay, or flow cytometry equipment and related laboratory...
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $19,045.00 on June 15, 2017, for S-MEM liquid, a specialized biomedical research consumable. Place of performance is San Diego, California. The ultimate completion date is June 14, 2018. Life Technologies Corporation is a wholly owned subsidiary of Thermo Fisher Scientific Inc. and competes as a large, full-and-open prime contractor supplying specialized biomedical research instruments, reagents, and...
- The National Cancer Institute issued a delivery order to Life Technologies Corporation on June 6, 2019, with a ceiling value of $43,354.52 for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers. Place of performance is Grand Island, NY. The order is firm fixed price with an ultimate completion date of July 6, 2019. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific Inc. and specializes in biomedical research and genetic analysis...
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $24,898.13 on August 30, 2018, with ultimate completion on August 29, 2019. No set-aside category applied. Place of performance is Bethesda, Maryland. The purchase order uses fixed-price pricing with economic price adjustment. Life Technologies operates as Thermo Fisher Scientific and supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation on February 11, 2020, for drugs and biologicals with a ceiling value of $15,081.95. Place of performance is Grand Island, New York. The order is firm fixed price with an ultimate completion date of March 31, 2020.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on March 22, 2018, for $24,531.78, with completion by May 31, 2018. The order procures laboratory supplies and consumables. Place of performance is Carlsbad, California.</p>